Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 3/2015

01-11-2015 | Original Article

Cardiovascular risk profile, diabetes specific factors, and prevalent microvascular eye complications in sub-Saharan Africans with type 2 diabetes

Authors: Andre P. Kengne, Patricia Gouking, Edvine Wawo, Godefroy Koki, Eric Balti, Herbert Hakapoka, Mesmin Y. Dehayem, Eugene Sobngwi, Jean-Claude Mbanya

Published in: International Journal of Diabetes in Developing Countries | Special Issue 3/2015

Login to get access

Abstract

The aim of this study is to examine the association between cardiovascular risk profile, diabetes-specific factors, and prevalent retinopathy in sub-Saharan Africans with type 2 diabetes. We enrolled 213 (41 % women) diabetic adults from the Cameroon National Obesity Center in 2008. Prevalent retinopathy was based on history and digital mydriatic retinal photography. Cardiovascular risk profile was assessed, and global absolute coronary risk was estimated with the UK Prospective Diabetes Study (UKPDS) and Framingham coronary risk equations. Logistic regressions were used to relate risk factors to prevalent retinopathy and discrimination and calibration assessed. Fifty-four patients (25.4 %) had prevalent of retinopathy. Patients with retinopathy had more often hypertension (88 vs 43 %, p = 0.003), and age at diagnosis, known duration of diabetes, blood glucose, and systolic blood pressure were associated with retinopathy. Estimated 10-year coronary risks by the Framingham and UKPDS had low discrimination for retinopathy, with C-statistic (95 % confidence interval) of 0.593 (0.504–0.682) and 0.603 (0.518–0.688), respectively. New equations developed from this sample had better discrimination and calibration, with a maximum C-statistic of 0.881 (0.828–0.933). Cardiovascular risk profile was poorly correlated with prevalent retinopathy in this population. Strategies based upon routinely assessed diabetes-related factors can improve the selection of patients at high risk of retinopathy for costly confirmatory investigations.
Literature
1.
go back to reference International Diabetes Federation. Diabetes Atlas. 4th ed. Brussels: IDF. 2009. International Diabetes Federation. Diabetes Atlas. 4th ed. Brussels: IDF. 2009.
2.
go back to reference Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72.PubMedCrossRef Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72.PubMedCrossRef
3.
go back to reference Kengne AP, Patel A, Marre M, Travert F, Lievre M, Zoungas S, et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil. 2011;18(3):393–8. doi: 0.1177/1741826710394270. Kengne AP, Patel A, Marre M, Travert F, Lievre M, Zoungas S, et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil. 2011;18(3):393–8. doi: 0.1177/1741826710394270.
4.
go back to reference Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med. 2009;55(2):92–6.PubMedCrossRef Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med. 2009;55(2):92–6.PubMedCrossRef
5.
go back to reference Chatziralli IP, Sergentanis TN, Keryttopoulos P, Vatkalis N, Agorastos A, Papazisis L. Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. BMC Res Notes. 2010;3:153.PubMedPubMedCentralCrossRef Chatziralli IP, Sergentanis TN, Keryttopoulos P, Vatkalis N, Agorastos A, Papazisis L. Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. BMC Res Notes. 2010;3:153.PubMedPubMedCentralCrossRef
6.
go back to reference Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115(11):1869–75.PubMedCrossRef Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115(11):1869–75.PubMedCrossRef
7.
go back to reference Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M. Risk factors for diabetic retinopathy in a south Indian type 2 diabetic population—the Chennai urban rural epidemiology study (CURES) Eye study 4. Diabet Med. 2008;25(5):536–42.PubMedCrossRef Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M. Risk factors for diabetic retinopathy in a south Indian type 2 diabetic population—the Chennai urban rural epidemiology study (CURES) Eye study 4. Diabet Med. 2008;25(5):536–42.PubMedCrossRef
8.
go back to reference Dowse GK, Humphrey AR, Collins VR, Plehwe W, Gareeboo H, Fareed D, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol. 1998;147(5):448–57.PubMedCrossRef Dowse GK, Humphrey AR, Collins VR, Plehwe W, Gareeboo H, Fareed D, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol. 1998;147(5):448–57.PubMedCrossRef
9.
go back to reference Owens DR, Volund A, Jones D, Shannon AG, Jones IR, Birtwell AJ, et al. Retinopathy in newly presenting non-insulin-dependent (type 2) diabetic patients. Diabetes Res. 1988;9(2):59–65.PubMed Owens DR, Volund A, Jones D, Shannon AG, Jones IR, Birtwell AJ, et al. Retinopathy in newly presenting non-insulin-dependent (type 2) diabetic patients. Diabetes Res. 1988;9(2):59–65.PubMed
10.
go back to reference Kengne AP, Djouogo CF, Dehayem MY, Fezeu L, Sobngwi E, Lekoubou A, et al. Admission trends over 8 years for diabetic foot ulceration in a specialized diabetes unit in Cameroon. Int J Low Extrem Wounds. 2009;8(4):180–6.PubMedCrossRef Kengne AP, Djouogo CF, Dehayem MY, Fezeu L, Sobngwi E, Lekoubou A, et al. Admission trends over 8 years for diabetic foot ulceration in a specialized diabetes unit in Cameroon. Int J Low Extrem Wounds. 2009;8(4):180–6.PubMedCrossRef
11.
go back to reference D’Agostino Sr RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53.PubMedCrossRef D’Agostino Sr RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53.PubMedCrossRef
12.
go back to reference Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101(6):671–9.CrossRef Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101(6):671–9.CrossRef
13.
go back to reference Koki G, Bella AL, Omgbwa EA, Epee E, Sobngwi E, Kouanang KA, et al. [Diabetic retinopathy in black Africans: an angiographic study]. Sante. 2010;20(3):127–32.PubMed Koki G, Bella AL, Omgbwa EA, Epee E, Sobngwi E, Kouanang KA, et al. [Diabetic retinopathy in black Africans: an angiographic study]. Sante. 2010;20(3):127–32.PubMed
14.
go back to reference Massin P, Angioi-Duprez K, Bacin F, Cathelineau B, Cathelineau G, Chaine G, et al. Detection, monitoring and treatment of diabetic retinopathy. Recommendations of ALFEDIAM. Committee of above-mentioned experts and validated by the board of directors and scientific board of ALFEDIAM. Diabetes Metab. 1996;22(3):203–9.PubMed Massin P, Angioi-Duprez K, Bacin F, Cathelineau B, Cathelineau G, Chaine G, et al. Detection, monitoring and treatment of diabetic retinopathy. Recommendations of ALFEDIAM. Committee of above-mentioned experts and validated by the board of directors and scientific board of ALFEDIAM. Diabetes Metab. 1996;22(3):203–9.PubMed
15.
go back to reference Nguyen HT, Luzio SD, Dolben J, West J, Beck L, Coates PA, et al. Dominant risk factors for retinopathy at clinical diagnosis in patients with type II diabetes mellitus. J Diabetes Complications. 1996;10(4):211–9.PubMedCrossRef Nguyen HT, Luzio SD, Dolben J, West J, Beck L, Coates PA, et al. Dominant risk factors for retinopathy at clinical diagnosis in patients with type II diabetes mellitus. J Diabetes Complications. 1996;10(4):211–9.PubMedCrossRef
16.
go back to reference Al-Zuabi H, Al-Tammar Y, Al-Moataz R, Al-Sabti K, Wani VB, Hamama F, et al. Retinopathy in newly diagnosed type 2 diabetes mellitus. Med Princ Pract. 2005;14(5):293–6.PubMedCrossRef Al-Zuabi H, Al-Tammar Y, Al-Moataz R, Al-Sabti K, Wani VB, Hamama F, et al. Retinopathy in newly diagnosed type 2 diabetes mellitus. Med Princ Pract. 2005;14(5):293–6.PubMedCrossRef
17.
go back to reference Chen MS, Kao CS, Chang CJ, Wu TJ, Fu CC, Chen CJ, et al. Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am J Ophthalmol. 1992;114(6):723–30.PubMedCrossRef Chen MS, Kao CS, Chang CJ, Wu TJ, Fu CC, Chen CJ, et al. Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am J Ophthalmol. 1992;114(6):723–30.PubMedCrossRef
18.
go back to reference Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130(6):515–24.PubMedCrossRef Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130(6):515–24.PubMedCrossRef
19.
go back to reference Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, et al. The Framingham and UKPDS risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the action in diabetes and vascular disease: preterax and diamicron-MR controlled evaluation (ADVANCE) study. Diabetologia. 2010;53(5):821–31.PubMedCrossRef Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, et al. The Framingham and UKPDS risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the action in diabetes and vascular disease: preterax and diamicron-MR controlled evaluation (ADVANCE) study. Diabetologia. 2010;53(5):821–31.PubMedCrossRef
20.
go back to reference International Diabetes Federation. Global guidelines for type 2 diabetes. Brussels: International Diabetes Federation, 2005. International Diabetes Federation. Global guidelines for type 2 diabetes. Brussels: International Diabetes Federation, 2005.
21.
go back to reference Mehlsen J, Erlandsen M, Poulsen PL, Bek T. Individualized optimization of the screening interval for diabetic retinopathy: a new model. Acta Ophthalmol. 2010;90(2):109–14. doi:10.1111/j.1755-3768.2010.01882.x. Mehlsen J, Erlandsen M, Poulsen PL, Bek T. Individualized optimization of the screening interval for diabetic retinopathy: a new model. Acta Ophthalmol. 2010;90(2):109–14. doi:10.1111/j.1755-3768.2010.01882.x.
22.
go back to reference Zoppini G, Verlato G, Targher G, Casati S, Gusson E, Biasi V, et al. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes? Nutr Metab Cardiovasc Dis. 2009;19(5):334–9.PubMedCrossRef Zoppini G, Verlato G, Targher G, Casati S, Gusson E, Biasi V, et al. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes? Nutr Metab Cardiovasc Dis. 2009;19(5):334–9.PubMedCrossRef
23.
go back to reference Takao T, Ide T, Yanagisawa H, Kikuchi M, Kawazu S, Matsuyama Y. The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up. Diabetes Res Clin Pract. 2010;89(3):296–302.PubMedCrossRef Takao T, Ide T, Yanagisawa H, Kikuchi M, Kawazu S, Matsuyama Y. The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up. Diabetes Res Clin Pract. 2010;89(3):296–302.PubMedCrossRef
24.
go back to reference Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients. Diabetes Metab. 2009;35(3):214–9.PubMedCrossRef Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients. Diabetes Metab. 2009;35(3):214–9.PubMedCrossRef
25.
go back to reference Arden GB, Sivaprasad S. The pathogenesis of early retinal changes of diabetic retinopathy. Doc Ophthalmol Adv Ophthalmol. 2012;124(1):15–26.CrossRef Arden GB, Sivaprasad S. The pathogenesis of early retinal changes of diabetic retinopathy. Doc Ophthalmol Adv Ophthalmol. 2012;124(1):15–26.CrossRef
26.
go back to reference Swanson M. Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost—an epidemiologic review. Optometry. 2005;76(11):636–46.PubMedCrossRef Swanson M. Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost—an epidemiologic review. Optometry. 2005;76(11):636–46.PubMedCrossRef
27.
go back to reference Li HK, Horton M, Bursell SE, Cavallerano J, Zimmer-Galler I, Tennant M, et al. Telehealth practice recommendations for diabetic retinopathy, second edition. Telemed J E Health. 2011;17(10):814–37.PubMedCrossRef Li HK, Horton M, Bursell SE, Cavallerano J, Zimmer-Galler I, Tennant M, et al. Telehealth practice recommendations for diabetic retinopathy, second edition. Telemed J E Health. 2011;17(10):814–37.PubMedCrossRef
28.
go back to reference Van Houwelingen HC. Validation, calibration, revision and combination of prognostic survival models. Stat Med. 2000;19(24):3401–15.PubMedCrossRef Van Houwelingen HC. Validation, calibration, revision and combination of prognostic survival models. Stat Med. 2000;19(24):3401–15.PubMedCrossRef
29.
go back to reference Grobbee D. HA. Clinical epidemiology: principle, methods and applications for clinical research: Jones & Bartlett. 2008. Grobbee D. HA. Clinical epidemiology: principle, methods and applications for clinical research: Jones & Bartlett. 2008.
Metadata
Title
Cardiovascular risk profile, diabetes specific factors, and prevalent microvascular eye complications in sub-Saharan Africans with type 2 diabetes
Authors
Andre P. Kengne
Patricia Gouking
Edvine Wawo
Godefroy Koki
Eric Balti
Herbert Hakapoka
Mesmin Y. Dehayem
Eugene Sobngwi
Jean-Claude Mbanya
Publication date
01-11-2015
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue Special Issue 3/2015
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-014-0283-y

Other articles of this Special Issue 3/2015

International Journal of Diabetes in Developing Countries 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.